开云app官网登录入口网页版-官方正版

#VAP#

21篇内容 | 1225人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1943348, encodeId=0568194334820, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=Nat Med：Avapritinib在晚期系统性肥大细胞增多症治疗中的安全性和疗效, objectType=article, longId=221678, objectId=c95b2216e828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c95b2216e828, replyNumber=0, likeNumber=0, createdTime=2022-05-04, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c95b2216e828, moduleTitle=Nat Med：Avapritinib在晚期系统性肥大细胞增多症治疗中的安全性和疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c95b2216e828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943349, encodeId=69781943349d2, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=Nat Med：晚期系统性肥大细胞增多症患者Avapritinib治疗的安全性和疗效, objectType=article, longId=221681, objectId=c0b722168126, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0b722168126, replyNumber=0, likeNumber=74, createdTime=2022-06-02, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0b722168126, moduleTitle=Nat Med：晚期系统性肥大细胞增多症患者Avapritinib治疗的安全性和疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c0b722168126)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943350, encodeId=db581943350f4, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=辉瑞的DMD基因疗法fordadistrogene movaparvovec在患者死亡后被FDA搁置, objectType=article, longId=292791, objectId=e037292e9125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e037292e9125, replyNumber=0, likeNumber=142, createdTime=2022-10-03, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e037292e9125, moduleTitle=辉瑞的DMD基因疗法fordadistrogene movaparvovec在患者死亡后被FDA搁置, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e037292e9125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943347, encodeId=5183194334ec6, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=J Clin Oncol：Avapritinib对比瑞戈非尼（Regorafenib）治疗局部进展不可切除或转移性胃肠道间质瘤的疗效：随机III期研究, objectType=article, longId=215316, objectId=4736215316ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4736215316ea, replyNumber=0, likeNumber=129, createdTime=2021-10-02, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4736215316ea, moduleTitle=J Clin Oncol：Avapritinib对比瑞戈非尼（Regorafenib）治疗局部进展不可切除或转移性胃肠道间质瘤的疗效：随机III期研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4736215316ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943345, encodeId=161c194334534, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=PDGFRα靶向新药avapritinib在中国台湾申请用于治疗晚期胃肠道间质瘤成人患者, objectType=article, longId=191054, objectId=22d01910546b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22d01910546b, replyNumber=0, likeNumber=74, createdTime=2020-07-18, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22d01910546b, moduleTitle=PDGFRα靶向新药avapritinib在中国台湾申请用于治疗晚期胃肠道间质瘤成人患者, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=22d01910546b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943346, encodeId=3e1019433467c, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=曹晖教授：Avapritinib力克耐药突变，GIST患者治疗迈向新高度, objectType=article, longId=196135, objectId=1ddd196135a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ddd196135a4, replyNumber=0, likeNumber=114, createdTime=2020-12-21, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ddd196135a4, moduleTitle=曹晖教授：Avapritinib力克耐药突变，GIST患者治疗迈向新高度, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1ddd196135a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943344, encodeId=09b719433449d, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=拜耳收购不依赖激素的女性避孕产品Ovaprene，药效可维持1个月, objectType=article, longId=186396, objectId=9ac8186396fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ac8186396fa, replyNumber=0, likeNumber=77, createdTime=2020-07-10, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ac8186396fa, moduleTitle=拜耳收购不依赖激素的女性避孕产品Ovaprene，药效可维持1个月, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9ac8186396fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943342, encodeId=ed5b194334224, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=第五届呼吸危重症论坛 | 范红：中国成人医院获得性肺炎与呼吸机相关性肺炎（HAP/VAP）诊断和治疗指南（2018）解读, objectType=article, longId=162948, objectId=588316294827, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=588316294827, replyNumber=0, likeNumber=100, createdTime=2019-12-29, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=588316294827, moduleTitle=第五届呼吸危重症论坛 | 范红：中国成人医院获得性肺炎与呼吸机相关性肺炎（HAP/VAP）诊断和治疗指南（2018）解读, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=588316294827)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943341, encodeId=ed641943341d0, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=CLIN CANCER RES：Avapritinib治疗胃肠道间质瘤, objectType=article, longId=159079, objectId=d1181590e960, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1181590e960, replyNumber=0, likeNumber=79, createdTime=2020-01-08, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1181590e960, moduleTitle=CLIN CANCER RES：Avapritinib治疗胃肠道间质瘤, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d1181590e960)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943343, encodeId=6931194334378, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=AR-105治疗呼吸机相关性肺炎（VAP）的中期研究未能达到主要终点, objectType=article, longId=178801, objectId=7ef71e88018b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ef71e88018b, replyNumber=0, likeNumber=0, createdTime=2019-11-29, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ef71e88018b, moduleTitle=AR-105治疗呼吸机相关性肺炎（VAP）的中期研究未能达到主要终点, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7ef71e88018b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943339, encodeId=08271943339a5, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=J Gastroenterol Hepatol：在肝硬化肝水肿患者中，血清尿素水平和尿钠排泄与患者对tolvaptan药物应答密切相关, objectType=article, longId=140407, objectId=74bc14040ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74bc14040ecd, replyNumber=0, likeNumber=84, createdTime=2018-07-12, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74bc14040ecd, moduleTitle=J Gastroenterol Hepatol：在肝硬化肝水肿患者中，血清尿素水平和尿钠排泄与患者对tolvaptan药物应答密切相关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=74bc14040ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943340, encodeId=9f811943340b0, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=2018版中国成人HAP/VAP指南解读, objectType=article, longId=147861, objectId=fcad14e8612f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcad14e8612f, replyNumber=0, likeNumber=81, createdTime=2019-08-13, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcad14e8612f, moduleTitle=2018版中国成人HAP/VAP指南解读, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fcad14e8612f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943337, encodeId=59f8194333e47, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=J Gastroenterol Hepatol：BUN和尿钠水平与肝硬化肝源性腹水患者对托伐普坦（tolvaptan）的反应密切相关, objectType=article, longId=123370, objectId=93821233e033, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93821233e033, replyNumber=0, likeNumber=74, createdTime=2018-10-02, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93821233e033, moduleTitle=J Gastroenterol Hepatol：BUN和尿钠水平与肝硬化肝源性腹水患者对托伐普坦（tolvaptan）的反应密切相关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=93821233e033)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943338, encodeId=55501943338c5, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=FDA批准大冢tolvaptan用于治疗常染色体显性多囊肾病, objectType=article, longId=136505, objectId=b09113650549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b09113650549, replyNumber=0, likeNumber=81, createdTime=2019-04-04, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b09113650549, moduleTitle=FDA批准大冢tolvaptan用于治疗常染色体显性多囊肾病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b09113650549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943335, encodeId=50c4194333560, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=Gut：VAP-1可预测原发性硬化性胆管炎患者临床结局！, objectType=article, longId=96707, objectId=e66696e0716, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e66696e0716, replyNumber=0, likeNumber=73, createdTime=2017-08-29, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e66696e0716, moduleTitle=Gut：VAP-1可预测原发性硬化性胆管炎患者临床结局！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e66696e0716)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943334, encodeId=de2c19433348a, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=KIDNEY INT：在肾缺血再灌注损伤中VAP-1通过产生过氧化氢促进中性粒细胞浸润！, objectType=article, longId=92668, objectId=890792668fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=890792668fc, replyNumber=0, likeNumber=73, createdTime=2018-01-12, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=890792668fc, moduleTitle=KIDNEY INT：在肾缺血再灌注损伤中VAP-1通过产生过氧化氢促进中性粒细胞浸润！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=890792668fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943336, encodeId=5d591943336b6, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=Chest：阿米卡星磷霉素吸入系统辅助治疗革兰阴性VAP“有点悬”, objectType=article, longId=107041, objectId=11a010e04151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11a010e04151, replyNumber=0, likeNumber=107, createdTime=2017-12-26, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11a010e04151, moduleTitle=Chest：阿米卡星磷霉素吸入系统辅助治疗革兰阴性VAP“有点悬”, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=11a010e04151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943333, encodeId=13ac194333378, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=呼吸机相关性气管-支气管炎（VAT）和呼吸机相关性肺炎（VAP）的预后, objectType=article, longId=58317, objectId=3d4b5831e63, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4b5831e63, replyNumber=0, likeNumber=133, createdTime=2016-05-06, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4b5831e63, moduleTitle=呼吸机相关性气管-支气管炎（VAT）和呼吸机相关性肺炎（VAP）的预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3d4b5831e63)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943332, encodeId=c56e194333261, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=Chest：遵从VAP预防指南可显著减少呼吸机相关疾病的患病率和死亡率, objectType=article, longId=26372, objectId=1fae263e2d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fae263e2d2, replyNumber=0, likeNumber=84, createdTime=2014-01-30, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fae263e2d2, moduleTitle=Chest：遵从VAP预防指南可显著减少呼吸机相关疾病的患病率和死亡率, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1fae263e2d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943330, encodeId=b6771943330c9, content=<a href='/topic/show?id=ea82182e611' target=_blank style='color:#2F92EE;'>#VAP#</a>, objectTitle=CHEST：短程抗生素治疗对VAP患者有效, objectType=article, longId=22683, objectId=e6d222683b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6d222683b3, replyNumber=0, likeNumber=87, createdTime=2013-12-31, rootId=0, userName=hxzhang, userId=4f9e287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6d222683b3, moduleTitle=CHEST：短程抗生素治疗对VAP患者有效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e6d222683b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

VAP

2020-05-29

hxzhang (审核中...)

前往app查看评论内容

#VAP#

Nat Med：Avapritinib在晚期系统性肥大细胞增多症治疗中的安全性和疗效

2022-05-04

hxzhang (审核中...)

前往app查看评论内容

#VAP#

Nat Med：晚期系统性肥大细胞增多症患者Avapritinib治疗的安全性和疗效

2022-06-02

hxzhang (审核中...)

前往app查看评论内容

#VAP#

辉瑞的DMD基因疗法fordadistrogene movaparvovec在患者死亡后被FDA搁置

2022-10-03

hxzhang (审核中...)

前往app查看评论内容

#VAP#

J Clin Oncol：Avapritinib对比瑞戈非尼（Regorafenib）治疗局部进展不可切除或转移性胃肠道间质瘤的疗效：随机III期研究

2021-10-02

hxzhang (审核中...)

前往app查看评论内容

#VAP#

PDGFRα靶向新药avapritinib在中国台湾申请用于治疗晚期胃肠道间质瘤成人患者

2020-07-18

hxzhang (审核中...)

前往app查看评论内容

#VAP#

曹晖教授：Avapritinib力克耐药突变，GIST患者治疗迈向新高度

2020-12-21

hxzhang (审核中...)

前往app查看评论内容

#VAP#

拜耳收购不依赖激素的女性避孕产品Ovaprene，药效可维持1个月

2020-07-10

hxzhang (审核中...)

前往app查看评论内容

#VAP#

第五届呼吸危重症论坛 | 范红：中国成人医院获得性肺炎与呼吸机相关性肺炎（HAP/VAP）诊断和治疗指南（2018）解读

2019-12-29

hxzhang (审核中...)

前往app查看评论内容

#VAP#

CLIN CANCER RES：Avapritinib治疗胃肠道间质瘤

2020-01-08

hxzhang (审核中...)

前往app查看评论内容

#VAP#

AR-105治疗呼吸机相关性肺炎（VAP）的中期研究未能达到主要终点

2019-11-29

hxzhang (审核中...)

前往app查看评论内容

#VAP#

J Gastroenterol Hepatol：在肝硬化肝水肿患者中，血清尿素水平和尿钠排泄与患者对tolvaptan药物应答密切相关

2018-07-12

hxzhang (审核中...)

前往app查看评论内容

#VAP#

2018版中国成人HAP/VAP指南解读

2019-08-13

hxzhang (审核中...)

前往app查看评论内容

#VAP#

J Gastroenterol Hepatol：BUN和尿钠水平与肝硬化肝源性腹水患者对托伐普坦（tolvaptan）的反应密切相关

2018-10-02

hxzhang (审核中...)

前往app查看评论内容

#VAP#

FDA批准大冢tolvaptan用于治疗常染色体显性多囊肾病

2019-04-04

hxzhang (审核中...)

前往app查看评论内容

#VAP#

Gut：VAP-1可预测原发性硬化性胆管炎患者临床结局！

2017-08-29

hxzhang (审核中...)

前往app查看评论内容

#VAP#

KIDNEY INT：在肾缺血再灌注损伤中VAP-1通过产生过氧化氢促进中性粒细胞浸润！

2018-01-12

hxzhang (审核中...)

前往app查看评论内容

#VAP#

Chest：阿米卡星磷霉素吸入系统辅助治疗革兰阴性VAP“有点悬”

2017-12-26

hxzhang (审核中...)

前往app查看评论内容

#VAP#

呼吸机相关性气管-支气管炎（VAT）和呼吸机相关性肺炎（VAP）的预后

2016-05-06

hxzhang (审核中...)

前往app查看评论内容

#VAP#

Chest：遵从VAP预防指南可显著减少呼吸机相关疾病的患病率和死亡率

2014-01-30

hxzhang (审核中...)

前往app查看评论内容

#VAP#

CHEST：短程抗生素治疗对VAP患者有效

2013-12-31

科室
- - 订阅+
  - 更多科室
工具
服务